ASK REDCHAT® ANYTHING ABOUT KINIKSA PHARMACEUTICALS, LTD.
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA)
Listen to this Section
$19.42
+0.6760
(
+3.28% )
181.1K
Market Data
Open |
$19.42 |
Previous Close |
$18.74 |
Volume |
181.1K |
Market Cap |
$1.35B |
Day Range |
$18.25 - $19.84 |
52 Week Range |
$16.56 - $28.15 |
Shares Outstanding |
72.20M |
Change % |
+3.28% |
Net Change |
▲ 0.6760 |
Insider Ownership |
-0.02% |
Exchange |
NASDAQ |
Sector |
Healthcare |
Industry |
Drug Manufacturers - Specialty & Generic |
IPO Year |
2018 |
Country |
United States |
Under Writer |
IPO Intelligence Only |
Analyst Insights
You need to login to view this content.
Insider Ownership Transactions
Total Amount Purchased:
-449,791.00
Date |
Type |
Amount Purchased |
Purchaser |
2024-07-25 |
Sale |
-136124.00 |
Patel Sanj K |
2024-07-25 |
Sale |
-22000.00 |
Paolini John F. |
2024-07-25 |
Sale |
-24248.00 |
Ragosa Mark |
2024-06-07 |
Sale |
-6346.00 |
BAKER BROS. ADVISORS LP |
2024-06-07 |
Sale |
-4373.00 |
Levy Richard S |
2024-06-07 |
Sale |
-4373.00 |
McCain Tracey L |
2024-06-07 |
Sale |
-4373.00 |
Malley Thomas |
2024-06-07 |
Sale |
-4373.00 |
Cole G Bradley |
2024-06-07 |
Sale |
-4373.00 |
Quart Barry D |
2024-06-07 |
Sale |
-4373.00 |
Popovits Kimberly J |
Institutional Ownership
Total Market Value
$ 0.00
SEC Fillings
Form Type |
Description |
Pages |
Date |
4 |
Insider transactions |
1 |
May 07, 2024 |
4 |
Insider transactions |
1 |
Apr 30, 2024 |
10-q |
Quarterly Reports |
73 |
Apr 25, 2024 |
ars |
Annual reports |
1 |
Apr 23, 2024 |
8-k |
8K-related |
15 |
Apr 23, 2024 |
def |
Proxies and info statements |
23 |
Apr 23, 2024 |
pre |
Proxies and info statements |
24 |
Apr 10, 2024 |
4 |
Insider transactions |
1 |
Apr 08, 2024 |
4 |
Insider transactions |
1 |
Apr 08, 2024 |
4 |
Insider transactions |
1 |
Apr 08, 2024 |